3D nanomatrix vascular sheet model for high-throughput atherosclerosis drug...
A groundbreaking 3D, three-layer nanomatrix vascular sheet that possesses multiple features of atherosclerosis has been applied for developing a high-throughput functional assay of drug candidates to...
View ArticleScientists identify a new approach to treating sarcoidosis
A research team led by Georg Stary (Medical University of Vienna and CeMM) has identified a new approach to treating the inflammatory disease sarcoidosis.
View ArticleNovel drug combination shows promise for treating advanced skin cancers in...
People who have had a kidney transplant are at high risk for developing skin cancers. New research directed by investigators from the Johns Hopkins Kimmel Cancer Center is exploring the best...
View ArticleTCT 2024 to feature latest advances in interventional cardiovascular medicine
The Cardiovascular Research Foundation is pleased to announce the late-breaking clinical trials and science to be featured at TCT 2024.
View ArticleKey triggers for food allergies in children after organ transplants
Study reviews transplant-acquired food allergies, focusing on pediatric patients, particularly liver transplant recipients. It explores immune system dysfunction, immunosuppressive agents, and gut...
View ArticleSirolimus-eluting balloon strategy matches drug-eluting stents in large...
New study results from a large international all-comer population of percutaneous coronary intervention (PCI) candidates found that utilizing a strategy of sirolimus-eluting balloons with bailout...
View ArticleLandmark trial shows drug-eluting balloon as effective option for in-stent...
Results from the first randomized clinical trial in the United States to compare a sirolimus-eluting balloon (DEB) to control group consisting of drug-eluting stent (DES) and balloon angioplasty (BA)...
View ArticleSirolimus-eluting balloon emerges as a safe and effective option for coronary...
A new drug-eluting balloon can perform just as well as the standard treatment for patients with coronary in-stent restenosis (ISR) undergoing repeated percutaneous coronary intervention (PCI).
View ArticleMilken Institute and Ann Theodore Foundation fund mTOR inhibitor trial for...
The Milken Institute Science Philanthropy Accelerator for Research and Collaboration (SPARC), in partnership with the Ann Theodore Foundation (ATF), has launched a new funding program to support a...
View ArticleDrug-coated balloons reduce the need for permanent heart stents
A new sub-study suggests that using a sirolimus-eluting balloon (SEB), a drug-coated balloon, can reduce the number of stents a patient may need, making it a safe and effective way to treat certain...
View Article
![Pat Metheny Group – Travels (1983) [Japan 2017] [SACD ISO + Hi-Res FLAC]](http://imghd.xyz/images/2022/10/09/zWqOXMz.jpg)
